Hasegawa I, Tani H, Takakuwa K, Yamada K, Kanazawa K, Tanaka K
Department of Obstetrics and Gynecology, Niigata University School of Medicine, Japan.
Fertil Steril. 1992 Feb;57(2):445-7. doi: 10.1016/s0015-0282(16)54862-6.
Immunotherapy with paternal lymphocytes for unexplained recurrent aborters was applied, preceding IVF-ET, for infertile women with repeated failure of ET. In one patient showing close histocompatibility with the husband, the subsequent new IVF-ET was successful under positive MLR-blocking antibody induced by immunotherapy.
对于不明原因复发性流产患者，在体外受精-胚胎移植（IVF-ET）之前，采用丈夫淋巴细胞免疫疗法，用于胚胎移植反复失败的不孕女性。在一名与丈夫组织相容性相近的患者中，在免疫疗法诱导的阳性混合淋巴细胞反应（MLR）阻断抗体作用下，随后进行的新IVF-ET取得成功。
